Michael T. McCaul bought Novo Nordisk A/S (NYSE: NVO)
Michael T. McCaul (R-TX), a U.S. Representative, has disclosed 23 trades in Novo Nordisk A/S (NVO) since 2024, 15 purchases and 8 sales, worth an estimated $1.1M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Michael T. McCaul bought $15,001 - $50,000 of Novo Nordisk A/S (NYSE: NVO) on April 24, 2024. Since that trade, NVO is down -56.26% against the S&P 500 up +50.32%, an outperformance of -106.58%.
Across these filings, Michael T. McCaul has been a net buyer of NVO (a buy-to-sell ratio of 1.88). The most recent disclosed NVO transaction shown was dated July 1, 2025. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Michael T. McCaul's NVO trades vs the price
NVO is down -56.26% since Michael T. McCaul bought on April 24, 2024, versus +50.32% for the S&P 500.
Performance since this trade
All Michael T. McCaul NVO trades
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
Michael T. McCaul & NVO trading FAQ
Is it legal for Michael T. McCaul to trade Novo Nordisk A/S (NVO) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Novo Nordisk A/S (NVO), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Michael T. McCaul buy NVO?
Michael T. McCaul disclosed a purchase of $15,001 - $50,000 of Novo Nordisk A/S (NVO) on April 24, 2024, according to public STOCK Act filings.
How has NVO performed since Michael T. McCaul's trade?
Since Michael T. McCaul bought NVO on April 24, 2024, the stock is down -56.26%, versus +50.32% for the S&P 500 over the same period, an outperformance of -106.58%.
How many times has Michael T. McCaul traded NVO?
Michael T. McCaul has disclosed 23 NVO trades since 2024 (15 purchases and 8 sales). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional NVO trades?
Quantellect tracks every disclosed congressional trade in Novo Nordisk A/S (NVO) on the Novo Nordisk A/S congressional trading page, which aggregates filings across all members of Congress.
Michael T. McCaul's NVO tradesAll congressional filings for Novo Nordisk A/SMichael T. McCaul's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.